Fumaric Acid

Fumaric Acid

SCHEMBL5248124

O=C(O)/C=C/C(=O)O.O=C1c2ccccc2CN1CC1CCN(C/C(=N\O)c2ccc(F)cc2)CC1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A known ✓ P28223 5/20 0.70
DRD2 known ✓ P14416 2/20 0.41
HTR2C known ✓ P28335 2/20 0.41
HTR2B known ✓ P41595 1/20 0.38
HTR1A P08908 1/20 0.70
TMEM97 Q5BJF2 1/20 0.70
HTR7 P34969 2/20 0.45
DRD4 P21917 1/20 0.42
ACHE P22303 1/20 0.42
PARP1 P09874 1/20 0.40
KEAP1 Q14145 3/20 0.39
NFE2L2 Q16236 3/20 0.39
THRB P10828 1/20 0.39
SIGMAR1 Q99720 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL5248136 1.00 HTR2A (0.70) HTR2AHTR1ATMEM97HTR7DRD4
Fumaric Acid SCHEMBL5309445 1.00 HTR2A (0.70) HTR2AHTR1ATMEM97HTR7DRD4
SCHEMBL5250091 0.94 HTR2A (0.76) HTR2AHTR1ATMEM97HTR7DRD4
SCHEMBL5250089 0.94 HTR2A (0.76) HTR2AHTR1ATMEM97HTR7DRD4
Fumaric Acid SCHEMBL5251856 0.90 HTR2A (0.66) HTR2AHTR1ATMEM97HTR7DRD4
Fumaric Acid SCHEMBL5251859 0.90 HTR2A (0.66) HTR2AHTR1ATMEM97HTR7DRD4
Fumaric Acid SCHEMBL5253352 0.90 HTR2A (0.66) HTR2AHTR1ATMEM97HTR7DRD4
Fumaric Acid SCHEMBL5252108 0.89 HTR2A (0.65) HTR2AHTR1ATMEM97HTR7ACHE
Fumaric Acid SCHEMBL5251769 0.89 HTR2A (0.65) HTR2AHTR1ATMEM97HTR7ACHE
Fumaric Acid SCHEMBL5251778 0.89 HTR2A (0.65) HTR2AHTR1ATMEM97HTR7ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1260512-B1 NOVEL CYCLIC AMIDE DERIVATIVES MITSUBISHI PHARMA CORP (JP) 2007-07-04 EP disclosed
US-7166617-B2 Cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2007-01-23 US disclosed
US-20030212094-A1 Novel cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2003-11-13 US disclosed
EP-1260512-A1 NOVEL CYCLIC AMIDE DERIVATIVES Mitsubishi Pharma Corporation (JP) 2002-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212094-A1 Novel cyclic amide derivatives SIGMAR1, OPRM1, OPRD1 HTR2A 153/4885DRD2 402/4885HTR2C 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.